Novo Nordisk announced on March 4, 2024, that its clinical trials for an oral version of the Alzheimer’s drug semaglutide did not succeed in slowing the...
Novo Nordisk has announced significant price reductions for its obesity treatments, Wegovy and Ozempic, in an effort to compete more effectively against rival Eli Lilly, which...
Novo Nordisk has announced a significant price reduction for its weight-loss injection, Wegovy, by up to 37% in India. This strategic decision comes as the Danish...
Investment firm Virtus SGA has decided to liquidate its position in Novo Nordisk, citing significant concerns regarding the pharmaceutical company’s long-term growth prospects. This decision follows...
Shares in Novo Nordisk dropped by as much as 3 percent on Friday following a pricing agreement between the Danish pharmaceutical company and its U.S. competitor...
Pfizer has initiated legal proceedings against Metsera and Novo Nordisk in a Delaware court, following a recent bid by the Danish pharmaceutical company that surpasses Pfizer’s...
Wall Street experienced significant declines on September 29, 2023, following U.S. President Donald Trump‘s announcement of potential tariff increases on imports from China. Trump characterized China’s...
